ArticleJournal of health care for the poor and underserved2025
The Program Cost Effectiveness of a Safety-Net Hospital Program Expanding Social Needs Activities in Atlanta.
Article in Journal of health care for the poor and underserved, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transforming Advanced Heart Failure Programs: Addressing Institutional and Systemic Drivers of Racial and Ethnic Disparities in Care.Circulation. Heart failure · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The Grady Heart Failure Program (GHFP), based in a safety-net hospital, is an outpatient program that follows heart failure hospitalization. The 2018 GHFP added a community health worker, patient liaison, and mobile integrated health home visits to reduce socioeconomic barriers to treatment. Important outcomes for the GHFP included the program cost and patient follow-up visits within seven days of hospital discharge. We calculated the difference in 30-day related readmission between 2017 and 2018 to assess pre-post program effectiveness. Patient follow-up visits within seven days increased from 63.7% in 2017 to 65.6% in 2018. Related 30-day readmissions declined from 15.5% in 2017 to 13.1% in 2018. Compared with 2017, the incremental program cost per related 30-day hospital readmission averted was $7,955 in 2018. The expanded GHFP is potentially cost-saving from the perspective of the hospital-provider based on the inpatient cost saved from a heart failure readmission averted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.